Kevin McLaughlin

6PUBLICATIONS
16CO-AUTHORS
Social epidemiologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Catalysis and mechanisms of reactionsToxicology (incl. clinical toxicology)Pharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 29, 2023
Prevalence, risk factors, and outcomes associated with delayed second doses of antibiotics in sepsis at a large academic medical center.

Meghan E Cook, Brian R Schuler, Michael J Schontz

|May 02, 2022
Evaluation of the safety of 500 mg intravenous push thiamine at a tertiary academic medical center.

Mohammed Aldhaeefi, Kevin McLaughlin, Melanie Goodberlet

|Sep 10, 2021
Stability of alteplase for ultrasound-facilitated catheter-directed thrombolysis.

John Fanikos, Kathleen Marquis, Leo Buckley

|Jan 18, 2021
Safety of Intravenous Olanzapine Administration at a Tertiary Academic Medical Center.

Nicholas F Hunt, Kevin C McLaughlin, Mary P Kovacevic

|Jul 21, 2020
Safety of Intravenous Push Lacosamide Compared With Intravenous Piggyback at a Tertiary Academic Medical Center.

Kevin McLaughlin, Shannon Carabetta, Nicholas Hunt

|Sep 19, 2019
Evaluation of Antifactor-Xa Heparin Assay and Activated Partial Thromboplastin Time Values in Patients on Therapeutic Continuous Infusion Unfractionated Heparin Therapy.

Kevin McLaughlin, Jessica Rimsans, Katelyn W Sylvester

Pageof 1